

Back to report
Se Year: M… TH… DI… NSM TLM SLM FLM SO

BRAND FOCUS/N…
MTD Target BRAND
MTD Sales MTD % SKUMTD % MTD % CP QTD Target QTD Sales QTD % QTD % QTD % CP YTD Target YTD Sales YTD % YTD % YTD % CP
Ach Growth Growth Ach Growth Growth Ach Growth Growth
Dynamic Sele…
ABSENZ ORAL
SALES SOLUTION
PERFORMANCE 0.2
BY : BRAND 0.23 152.0% 143.8% 135.5% 0.15 0.23 152.0% 143.8% 137.7% 0.61 0.87 142.3% 150.3% 1
AGOPREX 0.0 0.02 72.6% 23.0% 14.3% 0.03 0.02 72.6% 23.0% 15.5% 0.14 0.10 76.9% -17.6% -
CANEURA ORAL SOLUTION 0.2 0.32 138.9% -100.0% -100.0% 0.23 0.32 138.9% -100.0% -100.0% 0.94 1.34 142.5% -100.0% -1
EMAXGALIN 0.0 0.04 84.2% -23.9% -30.0% 0.04 0.04 84.2% -23.9% -31.3% 0.17 0.19 108.8% 8.7%
EXZILOR 0.0 0.00 -1.3% -101.2% -101.4% 0.03 0.00 -1.3% -101.2% -101.1% 0.14 0.05 38.0% -56.7% -
FULNITE 0.0 0.02 87.7% 23.1% 8.3% 0.02 0.02 87.7% 23.1% 9.8% 0.07 0.04 52.8% -57.9% -
GALAMER 0.0 0.03 115.6% 4.7% -0.9% 0.02 0.03 115.6% 4.7% -3.9% 0.09 0.08 80.3% -52.6% -
GRAVITOR 0.9 1.00 116.2% 11.6% 2.2% 0.86 1.00 116.2% 11.6% 2.4% 3.40 3.95 116.3% 21.5%
LACOSET 3.7 3.42 91.9% 5.2% -3.3% 3.72 3.42 91.9% 5.2% -3.2% 14.73 15.52 105.3% 17.7%
Go to Unit
MAXGALIN 2.4 1.80 74.1% -4.6% -8.8% 2.43 1.80 74.1% -4.6% -8.8% 9.61 8.34 86.8% 6.5%
MAXGALIN M 0.5 0.90 170.6% 7.7% 15.2% 0.52 0.90 170.6% 7.7% 15.1% 2.08 2.41 115.7% -3.6%
MAXGALIP AT 0.5 0.70 132.4% 20.3% 14.1% 0.53 0.70 132.4% 20.3% 14.0% 2.09 2.67 128.1% 29.4%
OLEANZ 2.4 2.72 111.2% 12.7% 5.7% 2.44 2.72 111.2% 12.7% 5.7% 9.68 11.41 117.9% 22.2%
ROPARK 2.2 2.16 98.4% 1.2% -4.0% 2.20 2.16 98.4% 1.2% -3.9% 8.72 10.14 116.4% 15.3%
STROCIT 6.6 8.09 121.8% 25.2% 21.5% 6.64 8.09 121.8% 25.2% 21.6% 26.34 30.81 117.0% 16.7%
SUMINAT 0.3 0.24 84.4% -24.4% -24.2% 0.29 0.24 84.4% -24.4% -24.3% 1.14 1.11 97.5% -13.5% -
TETRAFOL 0.8 0.39 49.7% -50.8% -54.2% 0.78 0.39 49.7% -50.8% -54.3% 3.08 2.60 84.6% -10.1% -
THEALIFE 0.1 0.05 72.2% -18.9% -24.6% 0.07 0.05 72.2% -18.9% -23.5% 0.29 0.32 109.6% 24.5%
TRANXIETY 0.0 0.14 0.00 0.14 0.00 0.28

BRAND MTD Target MTD Sales MTD % Ach MTD % Growth MTD % CP Growth QTD Target QTD Sales QTD % Ach QTD % Growth QTD % CP Growth YTD Target YTD Sales YTD % Ach YTD % Growth YTD

ABSENZ ORAL SOLUTION 0.2 0.23 152.0% 143.8% 135.5% 0.15 0.23 152.0% 143.8% 137.7% 0.61 0.87 142.3% 150.3%
AGOPREX 0.0 0.02 72.6% 23.0% 14.3% 0.03 0.02 72.6% 23.0% 15.5% 0.14 0.10 76.9% -17.6%
CANEURA ORAL SOLUTION 0.2 0.32 138.9% -100.0% -100.0% 0.23 0.32 138.9% -100.0% -100.0% 0.94 1.34 142.5% -100.0%
EMAXGALIN 0.0 0.04 84.2% -23.9% -30.0% 0.04 0.04 84.2% -23.9% -31.3% 0.17 0.19 108.8% 8.7%
EXZILOR 0.0 0.00 -1.3% -101.2% -101.4% 0.03 0.00 -1.3% -101.2% -101.1% 0.14 0.05 38.0% -56.7%
FULNITE 0.0 0.02 87.7% 23.1% 8.3% 0.02 0.02 87.7% 23.1% 9.8% 0.07 0.04 52.8% -57.9%
GALAMER 0.0 0.03 115.6% 4.7% -0.9% 0.02 0.03 115.6% 4.7% -3.9% 0.09 0.08 80.3% -52.6%
GRAVITOR 0.9 1.00 116.2% 11.6% 2.2% 0.86 1.00 116.2% 11.6% 2.4% 3.40 3.95 116.3% 21.5%
LACOSET 3.7 3.42 91.9% 5.2% -3.3% 3.72 3.42 91.9% 5.2% -3.2% 14.73 15.52 105.3% 17.7%
MAXGALIN 2.4 1.80 74.1% -4.6% -8.8% 2.43 1.80 74.1% -4.6% -8.8% 9.61 8.34 86.8% 6.5%
MAXGALIN M 0.5 0.90 170.6% 7.7% 15.2% 0.52 0.90 170.6% 7.7% 15.1% 2.08 2.41 115.7% -3.6%
MAXGALIP AT 0.5 0.70 132.4% 20.3% 14.1% 0.53 0.70 132.4% 20.3% 14.0% 2.09 2.67 128.1% 29.4%
OLEANZ 2.4 2.72 111.2% 12.7% 5.7% 2.44 2.72 111.2% 12.7% 5.7% 9.68 11.41 117.9% 22.2%
ROPARK 2.2 2.16 98.4% 1.2% -4.0% 2.20 2.16 98.4% 1.2% -3.9% 8.72 10.14 116.4% 15.3%
STROCIT 6.6 8.09 121.8% 25.2% 21.5% 6.64 8.09 121.8% 25.2% 21.6% 26.34 30.81 117.0% 16.7%
SUMINAT 0.3 0.24 84.4% -24.4% -24.2% 0.29 0.24 84.4% -24.4% -24.3% 1.14 1.11 97.5% -13.5%
TETRAFOL 0.8 0.39 49.7% -50.8% -54.2% 0.78 0.39 49.7% -50.8% -54.3% 3.08 2.60 84.6% -10.1%
THEALIFE 0.1 0.05 72.2% -18.9% -24.6% 0.07 0.05 72.2% -18.9% -23.5% 0.29 0.32 109.6% 24.5%
TRANXIETY 0.0 0.14 0.00 0.14 0.00 0.28
ZEPTOL 1.6 1.30 79.2% -18.8% -17.9% 1.65 1.30 79.2% -18.8% -17.9% 6.53 6.35 97.2% -7.1%
ZIPSYDON 0.2 0.13 81.9% -17.8% -24.4% 0.15 0.13 81.9% -17.8% -24.9% 0.61 0.67 109.3% -0.7%
ZOSERT 0.5 0.21 44.3% -47.2% -50.7% 0.47 0.21 44.3% -47.2% -50.6% 1.88 1.26 67.2% -17.8%
Total 23.3 23.90 102.6% 8.6% 4.2% 23.29 23.90 102.6% 8.6% 4.2% 92.32 100.50 108.9% 14.4%